Condition
Immunocompromised Patients clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Immunocompromised Patients clinical trials that are recruiting, at sites in 3 countries (most in Italy (4), Denmark (1), France (1)). 1 was first registered in the last 30 days. By phase: Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 1New in 30 days
- 3Countries
Newest Immunocompromised Patients clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Oral switch for bloodstream infections in immunocompromised children | Phase 4 | Aalborg and 3 other locations | Recruiting | Nov 6, 2026 |
| Biomarkers of Inflammation, Infection, and Immunity in Critically Ill Patients | — | Torino | Recruiting | Jul 6, 2026 |
| Personalized immunological score to predict severe infections in transplant and immunocompromised patients | — | Pavia, Lombardy | Recruiting | Jan 30, 2026 |
| Recombinant shingles vaccine for frail and immunocompromised adults | — | Pavia, Pavia | Recruiting | Jan 7, 2026 |
| Nasal immune responses to respiratory viruses in immunocompromised and healthy adults | — | Pavia, Pavia | Recruiting | Dec 19, 2025 |
| Better testing for Pneumocystis in people with weakened immune systems | — | Paris and 3 other locations | Recruiting | Mar 21, 2025 |
All recruiting trials (6)
-
Oral switch for bloodstream infections in immunocompromised children
This trial tests whether switching from IV to oral antibiotics is just as safe as continuing IV therapy for children with bloodstream infections who are immunocompromised or have a central venous catheter.
-
Biomarkers of Inflammation, Infection, and Immunity in Critically Ill Patients
This study tests whether blood biomarkers can predict illness severity and complications in adults admitted to intensive care with infection, including sepsis, and in immunocompromised or high-risk surgical patients.
-
Personalized immunological score to predict severe infections in transplant and immunocompromised patients
This project will test whether a personalized immunological score can predict serious infections in transplant and other immunocompromised patients and help tailor their care.
-
Recombinant shingles vaccine for frail and immunocompromised adults
This project will test whether a recombinant shingles (herpes zoster) vaccine produces protective immune responses and is safe in frail adults with weakened immune systems.
-
Nasal immune responses to respiratory viruses in immunocompromised and healthy adults
See how nasal immune responses to respiratory viruses differ between immunocompromised adults and healthy adults.
-
Better testing for Pneumocystis in people with weakened immune systems
This project will try a new qPCR test on non-invasive respiratory samples to see if it can detect Pneumocystis in immunocompromised adults compared with standard reference tests.
Related topics
Quick answers
How many Immunocompromised Patients clinical trials are recruiting right now?
6, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in Italy (4 trials), Denmark (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.